Enanta Pharmaceuticals (ENTA) Revenue Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -1.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.21% |
| Dec 31, 2025 | -7.59% |
| Sep 30, 2025 | -9.37% |
| Jun 30, 2025 | -2.03% |
| Mar 31, 2025 | -7.27% |
| Dec 31, 2024 | -15.03% |
| Sep 30, 2024 | -14.75% |
| Jun 30, 2024 | -5.98% |
| Mar 31, 2024 | -5.38% |
| Dec 31, 2023 | -17.23% |
| Sep 30, 2023 | -7.12% |
| Jun 30, 2023 | 0.43% |
| Mar 31, 2023 | -13.63% |
| Dec 31, 2022 | -23.45% |
| Sep 30, 2022 | -26.57% |
| Jun 30, 2022 | -24.00% |
| Mar 31, 2022 | -22.13% |
| Dec 31, 2021 | -26.59% |
| Sep 30, 2021 | -29.47% |
| Jun 30, 2021 | -27.72% |
| Mar 31, 2021 | -22.97% |
| Dec 31, 2020 | -5.91% |
| Sep 30, 2020 | -32.23% |
| Jun 30, 2020 | 35.42% |
| Mar 31, 2020 | 45.54% |
| Dec 31, 2019 | 71.53% |
| Sep 30, 2019 | 58.69% |
| Jun 30, 2019 | 46.96% |
| Mar 31, 2019 | 44.98% |
| Dec 31, 2018 | 12.99% |
| Sep 30, 2018 | 67.05% |
| Jun 30, 2018 | 70.27% |
| Mar 31, 2018 | -8.43% |
| Dec 31, 2017 | -21.07% |
| Sep 30, 2017 | 206.50% |
| Jun 30, 2017 | -43.68% |
| Mar 31, 2017 | 60.67% |
| Dec 31, 2016 | 126.79% |
| Sep 30, 2016 | 111.93% |
| Jun 30, 2016 | 103.90% |
| Mar 31, 2016 | 121.54% |
| Dec 31, 2015 | 20.25% |
| Sep 30, 2015 | 97.97% |
| Jun 30, 2015 | 65.86% |
| Mar 31, 2015 | 16.20% |